Furthermore, BNIP3L-mediated mitophagy might function as a tumor promoter with the evidence that Bnip3l depletion significantly delays the progression of pancreatic cancer and improves the survival in a murine model of pancreatic ductal adenocarcinoma [77]. The gene discussed is BNIP3L; the disease is pancreatic neoplasm.